The Lancet

The Lancet

Book and Periodical Publishing

The best science for better lives

About us

The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.

Website
http://www.thelancet.com
Industry
Book and Periodical Publishing
Company size
201-500 employees
Headquarters
London
Type
Public Company
Founded
1823
Specialties
publishing

Locations

Employees at The Lancet

Updates

  • View organization page for The Lancet, graphic

    143,522 followers

    Yesterday, our Series authors discussed the diverse challenges Asian nations face regarding the rising number of lung cancer incidences in the region. In case you missed it, you can now watch this webinar on-demand: https://hubs.li/Q02FRxss0 Our authors explored insights into drug development, the impact of climate change on lung cancer incidence, and the unique characteristics shaping the healthcare landscape for Asian populations.

    • No alternative text description for this image
  • View organization page for The Lancet, graphic

    143,522 followers

    Projections suggest more than 30 million people may be diagnosed with cancer in 2040, a 67% increase in 20 years. The global burden of cancer is immense, growing, and afflicts low- and middle-income countries most severely. “The public health response should be commensurately ambitious”, say co-chairs of an upcoming Lancet Commission: the CONCORD–Lancet Global Commission on Cancer. Learn more about the Commission’s purpose and aims ⤵️ https://hubs.li/Q02Fvl9G0

  • View organization page for The Lancet, graphic

    143,522 followers

    Last week, The Lancet Planetary Health's editorial team hosted a webinar exploring the journal's aims and scope. They also shared what they are looking for in a research paper and best practices to prepare your manuscript for publication in their journal. Couldn't join us live? Catch up now on-demand! Watch now: https://hubs.li/Q02zcXdT0

    • Watch on-demand. Publishing excellence with The Lancet Planetary Health. Copyright: Elsevier Ltd.
  • View organization page for The Lancet, graphic

    143,522 followers

    Nearly one third of adults worldwide did not meet the recommended levels of physical activity in 2022, suggests a new study in The Lancet Global Health. Explore the data 👉 https://hubs.li/Q02DPxN_0 Figures: Map of (A) age-standardised prevalence of insufficient physical activity among adults aged 18 years and over in 2022, (B) data coverage and representativeness, and (C) country progress during 2010–22 toward the global target of a 15% relative reduction in insufficient physical activity prevalence among adults aged 18 years and over between 2010 and 2030

    • No alternative text description for this image
  • View organization page for The Lancet, graphic

    143,522 followers

    Low back pain covers a spectrum of different types of pain that frequently overlap, e.g.: - Nociceptive - Neuropathic and nociplastic - Non-specific In The Lancet, a Seminar provides a brief overview of the epidemiology, causes, and risk factors that contribute to low back pain. Authors also describe different therapeutic options. To a large extent, therapy depends on pain classification. Read here: hubs.li/Q02CYWKK0 👇 Figure: Sagittal view of lumbar spine showing potential pain generators

    • No alternative text description for this image
  • View organization page for The Lancet, graphic

    143,522 followers

    Up until 2000, lung cancer was a highly lethal disease. The approval of a breakthrough therapy in 2003 and the identification of specific mutations on the EGFR gene a year later dramatically improved outcomes. Since then, there has been incredible progress. Yet for many patients, developments may not impact prognosis at all. New drugs can be hugely expensive, making them unaffordable in much of the world, and access to diagnostics and tumour profiling is often limited. In a new Editorial, The Lancet details lung cancer treatment over the last two decades ▶️ https://hubs.li/Q02D4hNX0

    • No alternative text description for this image
  • The Lancet reposted this

    View profile for Zoë Mullan, graphic

    Editor-in-Chief of The Lancet Global Health and I&D Lead for The Lancet Group

    The Lancet has updated its guidance for authors on reporting data on race and ethnicity. Mabel Chew, Diana Samuel, Sabine Kleinert and I explain the changes here. In brief, we encourage researchers to: 👉🏼 Include people from minoritised racial or ethnic populations as research participants 👉🏼 Report and analyse data by race or ethnicity or both, and if this isn't done, explain why (helps to understand what the barriers are) 👉🏼 Explain how race or ethnicity were defined 👉🏼 Discuss the full scope of potential drivers of observed disparities - particularly structural ones for which race/ethnicity might be a surrogate marker 👉🏼 Suggest positive solutions based on community strengths, rather than simply pointing out negative associations "We seek to transform systems, including our own, that have sustained these inequities and to find new paths to health and wellbeing, benefiting society as a whole. We invite our authors, reviewers, and readers to join us on this journey to healing." https://lnkd.in/eycNX4z5

    The Lancet Group's new guidance to authors on reporting race and ethnicity

    The Lancet Group's new guidance to authors on reporting race and ethnicity

    thelancet.com

  • View organization page for The Lancet, graphic

    143,522 followers

    There's still time to register! Join The Lancet Planetary Health's editorial team as they share the journal’s aims and scope, what they are looking for in a research paper, and best practices to prepare your manuscript for publication in their journal. Can't join us live? Register to receive the link to the on-demand version when it becomes available, to watch at your convenience. Register now: https://hubs.li/Q02zcXKx0 🗓️ Thurs, Jun 27, 2024 🕘 16:00 BST / 11:00 EDT

    • Join our webinar. Publishing excellence with The Lancet Planetary Health. Thurs, Jun 27, 2024, 16:00 BST/11:00 EDT. Copyright: Elsevier Ltd.
  • View organization page for The Lancet, graphic

    143,522 followers

    Gestational diabetes affects 1 in 7 pregnancies and is the most common medical pregnancy complication worldwide. Cases of gestational diabetes are increasing and becoming more complex due to higher levels of risk factors, such as obesity. Without treatment, gestational diabetes can lead to increased risk of: - High blood pressure - Caesarean sections - Mental health conditions - Health complications later in life, such as type 2 diabetes and cardiovascular disease - Complications for the baby at delivery Testing and treatment for the condition often occurs late into the second or third trimester. Authors of a new Lancet Series call for earlier intervention to prevent complications and improve long-term health outcomes. “Our new Series emphasises the urgent need for a major shift in how [gestational diabetes] is first diagnosed and managed, not only during pregnancy but throughout the lifetime of mothers and their babies,” said Series lead, Prof. David Simmons. Find out more ▶️ https://hubs.li/Q02C0SG30

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image

Similar pages

Browse jobs